title: Differential effects of progesterone and medroxyprogesterone on delay eyeblink conditioning in ovariectomized rats.
abstract: Ovarian hormones modulate acquisition processes involved in classical conditioning. Although progesterone has been indirectly implicated, its role in classical conditioning of the eyeblink response has not been directly investigated. We assessed the effects of daily dosing of progesterone or medroxyprogesterone (MPA), a non-metabolized synthetic progestin, upon the acquisition of a classically conditioned eyeblink response in ovariectomized (OVX) female rats. Rats were dosed 4h prior to each training session with 0.1 or 1.5 mg/kg of either of these hormones or sesame oil. A delay conditioning paradigm was employed using a 500 ms conditioned stimulus coterminating with a 10 ms 10 V unconditioned stimulus. At the low dose, progesterone and MPA rats did differ from each other, with MPA-treated rats learning slower, but neither group differed from OVX-oil or Sham-oil controls. No group differences in acquisition were observed at the higher dose. During extinction trials, high-dose MPA-treatment and OVX-oil groups extinguished quicker than the high-dose progesterone-treated group. In addition, unconditional response (UR) amplitudes were lower in all OVX groups, regardless of hormone or oil treatment, compared to the sham-oil group. Since MPA did not affect extinction, it is likely the slower extinction in the progesterone-treated rats is due to a metabolite of progesterone. Corticosterone is discussed as a likely candidate for such a role. In addition, we found chronic absence of ovarian hormones decreased UR amplitudes, although differences in UR amplitudes were not associated with changes in the acquisition process. These results are discussed with respect to differences in the hormonal effects upon acquisition versus extinction processes and how these data may explain reports of learning differences in women based on oral contraceptive usage.
authors.affiliation: Neurobehavioral Research Lab, VA New Jersey Health Care System, East Orange, NJ 07018, USA. beckkd@umdnj.edu
authors.forename: Kevin D
authors.initials: KD
authors.lastname: Beck
authors.forename: Michelle C
authors.initials: MC
authors.lastname: Wasserman
authors.forename: Stephanie J
authors.initials: SJ
authors.lastname: Furst
authors.forename: Kevin C H
authors.initials: KC
authors.lastname: Pang
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Servatius
mesh_terms: D000818:Animals; D003214:Conditioning, Classical / Q000187:drug effects*; D003215:Conditioning, Eyelid / Q000187:drug effects*; D005108:Extinction, Psychological / Q000187:drug effects*; D005260:Female; D008525:Medroxyprogesterone / Q000494:pharmacology*; D010052:Ovariectomy; D011374:Progesterone / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D011374:Progesterone; D008525:Medroxyprogesterone